oral liposomal bpc-157 BPC + KPV Combo Liposomal BPC - 1 fl.
Description
How AOD-9604 Works (in Brief) AOD-9604 was engineered from the C-terminal segment of human growth hormone (amino acids 177191) the portion thought to influence fat metabolism. In preclinical models, this fragment supported fat oxidation and lipid mobilization without the broader hormonal effects of full-length hGH. Because it does not activate the traditional hGH receptor, its fat-metabolism effects are considered indirect and receptor-independent. Discovery & Research Milestones Originally developed in the 1990s as a potential anti-obesity drug
8 August 2021
In conclusion, AOD 9604 is a peptide that has been studied for its potential benefits in weight management and fat reduction
2017 No serious adverse effects at therapeutic doses up to 1000 g/kg for 90 days
Lipotropic injections contain a combination of ingredients designed to promote weight loss, remove toxins, and provide energy
They are always so friendly and informative, and the staff is amazing
